Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Shock (Augusta, Ga.)|November 1, 2018
Incidence, Patient Characteristics, Mode of Drug Delivery, and Outcomes of Septic Shock Patients Treated With Vasopressors in the Arise TrialAndrew A Udy, Mark Finnis, Daryl Jones, et al.
Journal of Clinical Medicine|August 10, 2024
Practical Considerations for the Use of the Rapid AcuStar<sup>®</sup> ADAMTS13 Activity Assay in the Diagnosis of Acute Thrombotic Thrombocytopenic Purpura (TTP)Jun Yong, Stephen MacDonald, Colin Downey, et al.
International Journal of Laboratory Hematology|November 21, 2019
Characterization of a large cohort of patients with unclassified bleeding disorder; clinical features, management of haemostatic challenges and use of global haemostatic assessment with proposed recommendations for diagnosis and treatmentStephen MacDonald, Alfie Wright, Frederik Beuche, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|November 20, 2023
Assessing the impact of different heparin dosing regimens for cardiopulmonary bypass on anticoagulation: the HepDOSE pilot studyThar Nyan Lwin, Rahul Mudannayake, Stephen MacDonald, et al.
Blood|March 17, 2010
Integrin and CD3/TCR activation are regulated by the scaffold protein AKAP450Javier Robles-Valero, Noa B Martín-Cófreces, Amalia Lamana, et al.
Emergency Medicine Australasia : EMA|October 11, 2019
Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: A retrospective cohort studyAnthony Delaney, Mark Finnis, Rinaldo Bellomo, et al.
Scientific Reports|May 24, 2022
No association between intravenous fluid volume and endothelial glycocalyx shedding in patients undergoing resuscitation for sepsis in the emergency departmentStephen Macdonald, Erika Bosio, Nathan I Shapiro, et al.
Heart (British Cardiac Society)|June 27, 2025
Single high-sensitivity troponin levels to assess patients with potential acute coronary syndromes: 1-year outcomesCara Barnes, Frank M Sanfilippo, Daniel Michael Fatovich, et al.
BMC Nephrology|August 2, 2008
Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trialDavid Wayne Johnson, Carmel Mary Hawley, Brenda Rosser, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 7, 2025
The Laboratory Monitoring of Altuvoct (Efanesoctocog Alfa): Recommendations From the Laboratory Working Party of the United Kingdom Haemophilia Centres Doctor's OrganisationAnnette Elizabeth Bowyer, Mohammed Khan, Caroline Lawrence, et al.
Pageof 5